Holdco Nuvo Group D.g Ltd. · OTC:NUVOQ
Holdco Nuvo Group D.g — Investor Presentation (July 2024)
18 slides from Holdco Nuvo Group D.g's investor presentation, Jul 29, 2024
Slide 1: Remote Fetal Monitoring Company Overview
Vreni Loewen and Tatiana Lashina OB Solutions October 2022 R emote Fetal Monitoring Company Overview July 2024
Slide 2: Disclaimer
2 Disclaimer CAUTIONARY STATEMENT The information contained in this presentation (“Presentation”) has been prepared by Holdco Nuvo Group D.G Ltd., a limited li abi lity company organized under the laws of the State of Israel (“Nuvo”), and includes information pertaining to the business and operation
Slide 3: Forward Looking Statements
3 FORWARD LOOKING STATEMENTS Certain information set forth in the Presentation contains “forward - looking statements” as that term is defined under the Private Securities Litigation Reform Act of 1995 . Except for statements of historical fact, certain information contained herein constitutes forwa
Slide 4: Nuvo highlights
4 • De - risked platform - 2 FDA 510 (k) clearances 1 and CE mark pending • Commercial launch in March 2023 - now onboarding customers, monitoring patients and generating early revenue • Proven reimbursement - public and private payers • Philips Master Partnership Agreement signed August 2023 • Cont
Slide 5: INVU by Nuvo case study: Rural OB practice in Texas
5 INVU by Nuvo c ase s tudy Rural OB practice in Texas Three primary challenges : Maintaining Standard of Care T wice weekly NST’s was extremely difficult or impossible for most patients. High no - show rates and/or patients late to appointments, backing up schedule. Clinical Staff Workload Signific
Slide 6: Pregnancy care is broken
6 Pregnancy c are is broken Innovation in pregnancy care has lagged behind other healthcare practice areas M assive health equity issues in outcomes, access, and costs Contributing to Innovation has lagged Massive health equity issues
Slide 7: Key drivers creating tailwinds for Nuvo's business model
7 Key drivers creating tailwinds for Nuvo’s business model *Maternity care deserts are counties where there are no hospitals providing obstetric care, no birth centers, no OB/GYN and no certified nurse midwives. Notes : 1) AJOG 2015, 2) March of Dimes 2022, 3) AJMC 2019, 4) CDC 2021 Vital Statistics
Slide 8: A paradigm shift advancing pregnancy care
8 A paradigm shift advancing pregnancy care Antiquated technology in resource intensive clinical settings . Nuvo enables data - driven, actionable insights, anywhere , by everyone. Legacy Care Next Gen Care
Slide 9: Scalable pregnancy care for clinicians & expectant mothers
9 Scalable pregnancy care for clinicians & expectant mothers Unique Data Capture Signal Processing & Analysis Digital Tools & Services Collect Prescribe Compute Visualize Clinician - driven, prescription initiated Advancing the standard of care today and setting the foundation for tomorrow’s innovat
Slide 10: Fetal non-stress tests create opportunities across the healthcare ecosystem
10 Fetal non - stress tests create opportunities across the healthcare ecosystem x Convenience & quality of life x Care e mpowerment and reduced barriers of access to care x Reduced PTO, travel time & expense, etc x Improved staff efficiency x Increased revenue potential x Competitive differentiatio
Slide 11: Standard of care today and pioneering new care pathways tomorrow
11 Pre - eclampsia Maternal Mood Disorder Preterm Birth Diabetes Nuvo Data Cloud Maternal & Fetal ECG Maternal & Fetal PCG Standard of care today and pioneering new care pathways tomorrow Maternal & Fetal Heart Rate Maternal Uterine Activity (MUA) Transformational Care: AI and Predictive Analytics A
Slide 12: Value creation driven by innovation & distribution
12 Value c reation d riven by i nnovation & distribution Standard of Care : Remote Fetal Surveillance Upside via Innovation $ Current Offering $$$ $$ Clinical Decision Support Systems Transformational Care : Screening & Predictive Analytics Market Access Partners Anticipated International Markets Up
Slide 13: Reimbursement & public policy accelerators in remote pregnancy monitoring
13 Reimbursement & public policy accelerators In r emote p regnancy monitoring Public policy is funding improvements that address care equity Existing codes being utilized to reimburse remote NST’s by both public and private payers Remote NSTs reimbursed & endorsed Important Notice Regarding At - Ho
Slide 14: Nuvo increases access to care and generates deeper data insights
14 Only in - clinic, with medical assistance Access to Care At home & in - clinic Data Insights High - resolution, rich data sets We believe Nuvo is the only company that increases access to care and generates deeper data insights Archaic modalities
Slide 15: Patent Stats by Family
15 Patent Stats by Family ▪ Issued utility patents: ─ 16 U.S. / 44 Outside U.S. ▪ Pending utility patent applications: ─ 10 U.S. / 13 Outside U.S. ▪ Issued design patents: ─ 3 U.S. / 7 Outside U.S. One PCT patent application Nuvo’s IP a cts as a competitive b arrier to e ntry at every level of the p
Slide 16: Nuvo Public Company Leadership
16 Laurence Klein Founding Investor / Private Equity Fund Owner/Manager Board of Directors Christina Spade Former CEO of AMC Gerald Ostrov Board Chairman Former Chairman & CEO of Bausch + Lomb, Former Group Chairman J&J Nuvo Public Company Leadership Douglas Blankenship Chief Financial Officer Rice
Slide 17: Large & growing market in need of innovation
17 Large & growing market in need of innovation We believe Nuvo is one of the leading disruptors of status quo with 2 FDA 510(k) clearances 1 Go - to - market de - risked with commercial partnerships & reimbursed by certain existing codes Notes : 1) I NVU is cleared by the FDA for fetal heart rate,
Slide 18: The future of pregnancy care is in our hands
The future of pregnancy care is in our hands. Join the movement at nuvocares.com
Holdco Nuvo Group D.G — Investor Presentation (July 2024) on 6ix